{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:01:05Z","timestamp":1772668865737,"version":"3.50.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Heart Foundation of New Zealand","award":["HFNZ1936"],"award-info":[{"award-number":["HFNZ1936"]}]},{"DOI":"10.13039\/501100001518","name":"Maurice and Phyllis Paykel Trust","doi-asserted-by":"publisher","award":["221105"],"award-info":[{"award-number":["221105"]}],"id":[{"id":"10.13039\/501100001518","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["HRC 02\/152"],"award-info":[{"award-number":["HRC 02\/152"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-025-04751-3","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T09:43:22Z","timestamp":1744883002000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["VEGF-A cis-located SNPs on human chromosome 6 associated with VEGF-A plasma levels and survival in a coronary disease cohort"],"prefix":"10.1186","volume":"25","author":[{"given":"J. C.","family":"Meza-Alvarado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. P.","family":"Pilbrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. M.","family":"Frampton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. A.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M.","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. W.","family":"Troughton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. N.","family":"Doughty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. A.","family":"Page","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Mallard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bromhead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. R.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"issue":"1","key":"4751_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12963-023-00301-1","volume":"21","author":"N Wilson","year":"2023","unstructured":"Wilson N, et al. Prioritization of intervention domains to prevent cardiovascular disease: a country-level case study using global burden of disease and local data. Popul Health Metrics. 2023;21(1):1.","journal-title":"Popul Health Metrics"},{"issue":"3","key":"4751_CR2","first-page":"287","volume":"6","author":"R Roberts","year":"2021","unstructured":"Roberts R, Chang CC, Hadley T. Genetic risk stratification: A paradigm shift in prevention of coronary artery disease. J Am Coll Cardiology: Basic Translational Sci. 2021;6(3):287\u2013304.","journal-title":"J Am Coll Cardiology: Basic Translational Sci"},{"issue":"1","key":"4751_CR3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12872-018-0894-1","volume":"18","author":"ECA Marks","year":"2018","unstructured":"Marks ECA, et al. Plasma levels of soluble VEGF receptor isoforms, Circulating pterins and VEGF system SNPs as prognostic biomarkers in patients with acute coronary syndromes. BMC Cardiovasc Disord. 2018;18(1):169.","journal-title":"BMC Cardiovasc Disord"},{"issue":"7","key":"4751_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0254206","volume":"16","author":"BR Palmer","year":"2021","unstructured":"Palmer BR, et al. Vascular endothelial growth factor-A promoter polymorphisms, Circulating VEGF-A and survival in acute coronary syndromes. PLoS ONE. 2021;16(7):1\u201315.","journal-title":"PLoS ONE"},{"key":"4751_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcvm.2021.738325","volume":"8","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, et al. The role of the VEGF family in coronary heart disease. Front Cardiovasc Med. 2021;8:1\u201316.","journal-title":"Front Cardiovasc Med"},{"key":"4751_CR6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.redox.2017.01.007","volume":"12","author":"C Camar\u00e9","year":"2017","unstructured":"Camar\u00e9 C, et al. Angiogenesis in the atherosclerotic plaque. Redox Biol. 2017;12:18\u201334.","journal-title":"Redox Biol"},{"issue":"1","key":"4751_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom11010085","volume":"11","author":"S Niklander","year":"2021","unstructured":"Niklander S, et al. Vascular endothelial growth factor: A translational view in oral Non-Communicable diseases. Biomolecules. 2021;11(1):1\u201327.","journal-title":"Biomolecules"},{"issue":"12","key":"4751_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom10121673","volume":"10","author":"F Shaik","year":"2020","unstructured":"Shaik F, et al. Structural basis for vascular endothelial growth factor receptor activation and implications for disease therapy. Biomolecules. 2020;10(12):1\u201325.","journal-title":"Biomolecules"},{"issue":"10","key":"4751_CR9","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1111\/ijd.14127","volume":"57","author":"K Oszajca","year":"2018","unstructured":"Oszajca K, et al. Single-nucleotide polymorphisms of VEGF-A and VEGFR-2 genes and risk of infantile hemangioma. Int J Dermatol. 2018;57(10):1201\u20137.","journal-title":"Int J Dermatol"},{"issue":"6","key":"4751_CR10","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","volume":"176","author":"RS Apte","year":"2019","unstructured":"Apte RS, Chen DS, Ferrara N. VEGF in signaling and disease: beyond discovery and development. Cell. 2019;176(6):1248\u201364.","journal-title":"Cell"},{"issue":"10","key":"4751_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22105387","volume":"22","author":"THV Le","year":"2021","unstructured":"Le THV, Kwon SM. Vascular endothelial growth factor biology and its potential as a therapeutic target in rheumatic diseases. Int J Mol Sci. 2021;22(10):1\u201317.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4751_CR12","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.3390\/ijms19041264","volume":"19","author":"CJ Peach","year":"2018","unstructured":"Peach CJ, et al. Molecular Pharmacology of VEGF-A isoforms: binding and signalling at VEGFR2. Int J Mol Sci. 2018;19(4):1264.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4751_CR13","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s10545-015-9838-4","volume":"38","author":"GA Smith","year":"2015","unstructured":"Smith GA, et al. Vascular endothelial growth factors: multitasking functionality in metabolism, health and disease. J Inherit Metab Dis. 2015;38(4):753\u201363.","journal-title":"J Inherit Metab Dis"},{"issue":"15","key":"4751_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21155294","volume":"21","author":"M Braile","year":"2020","unstructured":"Braile M, et al. VEGF-A in cardiomyocytes and heart diseases. Int J Mol Sci. 2020;21(15):1\u201318.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"4751_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/JAHA.117.005619","volume":"6","author":"SL Au Yeung","year":"2017","unstructured":"Au Yeung SL, Lam H, Schooling CM. Vascular endothelial growth factor and ischemic heart disease risk: A Mendelian randomization study. J Am Heart Association. 2017;6(8):1\u20138.","journal-title":"J Am Heart Association"},{"key":"4751_CR16","doi-asserted-by":"publisher","first-page":"106060","DOI":"10.1016\/j.clineuro.2020.106060","volume":"196","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, et al. Serum vascular endothelial growth factor as a biomarker for prognosis of minor ischemic stroke. Clin Neurol Neurosurg. 2020;196:106060.","journal-title":"Clin Neurol Neurosurg"},{"issue":"4","key":"4751_CR17","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1399-0039.2010.01625.x","volume":"77","author":"L Rodr\u00edguez-Rodr\u00edguez","year":"2011","unstructured":"Rodr\u00edguez-Rodr\u00edguez L, et al. Vascular endothelial growth factor A and cardiovascular disease in rheumatoid arthritis patients. Tissue Antigens. 2011;77(4):291\u20137.","journal-title":"Tissue Antigens"},{"issue":"4","key":"4751_CR18","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1093\/cvr\/cvt148","volume":"99","author":"SE Heinonen","year":"2013","unstructured":"Heinonen SE, et al. The effects of VEGF-A on atherosclerosis, lipoprotein profile, and lipoprotein lipase in hyperlipidaemic mouse models. Cardiovascular Res. 2013;99(4):716\u201323.","journal-title":"Cardiovascular Res"},{"key":"4751_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/9185697","volume":"2020","author":"Z Zhao","year":"2020","unstructured":"Zhao Z, et al. Association between single nucleotide polymorphisms in cardiovascular developmental critical genes and hypertension: A propensity score matching analysis. Int J Hypertens. 2020;2020:1\u20138.","journal-title":"Int J Hypertens"},{"issue":"2","key":"4751_CR20","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41431-020-00730-8","volume":"29","author":"SE Ruotsalainen","year":"2021","unstructured":"Ruotsalainen SE, et al. An expanded analysis framework for multivariate GWAS connects inflammatory biomarkers to functional variants and disease. Eur J Hum Genet. 2021;29(2):309\u201324.","journal-title":"Eur J Hum Genet"},{"issue":"3\u20134","key":"4751_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/08977194.2018.1477141","volume":"36","author":"X Zhao","year":"2018","unstructured":"Zhao X, et al. Vascular endothelial growth factor gene polymorphisms and coronary heart disease: a systematic review and meta-analysis. Growth Factors. 2018;36(3\u20134):153\u201363.","journal-title":"Growth Factors"},{"issue":"2","key":"4751_CR22","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s11481-014-9531-7","volume":"9","author":"S Ramakrishnan","year":"2014","unstructured":"Ramakrishnan S, Anand V, Roy S. Vascular endothelial growth factor signaling in hypoxia and inflammation. J Neuroimmune Pharmacol. 2014;9(2):142\u201360.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"3","key":"4751_CR23","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cardiores.2004.09.032","volume":"65","author":"G Pag\u00e8s","year":"2005","unstructured":"Pag\u00e8s G, Pouyss\u00e9gur J. Transcriptional regulation of the vascular endothelial growth factor gene\u2013a concert of activating factors. Cardiovascular Res. 2005;65(3):564\u201373.","journal-title":"Cardiovascular Res"},{"issue":"18","key":"4751_CR24","doi-asserted-by":"publisher","first-page":"11947","DOI":"10.1016\/S0021-9258(18)99049-6","volume":"266","author":"E Tischer","year":"1991","unstructured":"Tischer E, et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem. 1991;266(18):11947\u201354.","journal-title":"J Biol Chem"},{"issue":"3","key":"4751_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijerph18030972","volume":"18","author":"P Singh","year":"2021","unstructured":"Singh P, et al. Genetic scores of eNOS, ACE and VEGFA genes are predictive of endothelial dysfunction associated osteoporosis in postmenopausal women. Int J Environ Res Public Health. 2021;18(3):1\u201318.","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"4751_CR26","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1161\/CIRCRESAHA.111.243790","volume":"109","author":"S Debette","year":"2011","unstructured":"Debette S, et al. Identification of cis- and trans-acting genetic variants explaining up to half the variation in Circulating vascular endothelial growth factor levels. Circul Res. 2011;109(5):554\u201363.","journal-title":"Circul Res"},{"issue":"2","key":"4751_CR27","first-page":"e1005874","volume":"12","author":"SH Choi","year":"2016","unstructured":"Choi SH, et al. Six novel loci associated with Circulating VEGF levels identified by a Meta-analysis of Genome-Wide association studies. Public Libr Sci (PLOS) Genet. 2016;12(2):e1005874.","journal-title":"Public Libr Sci (PLOS) Genet"},{"key":"4751_CR28","doi-asserted-by":"publisher","first-page":"1240288","DOI":"10.3389\/fcvm.2023.1240288","volume":"10","author":"H Chen","year":"2023","unstructured":"Chen H, et al. Variation in VEGFA and risk of cardiovascular disease in the UK biobank. Front Cardiovasc Med. 2023;10:1240288.","journal-title":"Front Cardiovasc Med"},{"key":"4751_CR29","doi-asserted-by":"crossref","unstructured":"Scott XO et al. Cohort study on the differential expression of inflammatory and angiogenic factors in thrombi, cerebral and peripheral plasma following acute large vessel occlusion stroke. J Cereb Blood Flow Metabolism, 2022: p. 271678x221106956.","DOI":"10.1177\/0271678X221106956"},{"issue":"3","key":"4751_CR30","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1540-8167.2011.02192.x","volume":"23","author":"BR Palmer","year":"2012","unstructured":"Palmer BR, et al. KCNE5 polymorphism rs697829 is associated with QT interval and survival in acute coronary syndromes patients. J Cardiovasc Electrophys. 2012;23(3):319\u201324.","journal-title":"J Cardiovasc Electrophys"},{"issue":"4","key":"4751_CR31","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.ahj.2008.06.013","volume":"156","author":"BR Palmer","year":"2008","unstructured":"Palmer BR, et al. Angiotensin-converting enzyme 2 A1075G polymorphism is associated with survival in an acute coronary syndromes cohort. Am Heart J. 2008;156(4):752\u20138.","journal-title":"Am Heart J"},{"issue":"6","key":"4751_CR32","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1161\/CIRCGENETICS.111.960336","volume":"4","author":"KL Ellis","year":"2011","unstructured":"Ellis KL, et al. Genomic risk variants at 1p13.3, 1q41, and 3q22.3 are associated with subsequent cardiovascular outcomes in healthy controls and in established coronary artery disease. Circulation Cardiovasc Genet. 2011;4(6):636\u201346.","journal-title":"Circulation Cardiovasc Genet"},{"issue":"1","key":"4751_CR33","doi-asserted-by":"publisher","first-page":"4605","DOI":"10.1038\/s41598-021-84046-7","volume":"11","author":"M Lass\u00e9","year":"2021","unstructured":"Lass\u00e9 M, et al. Fibrinogen and hemoglobin predict near future cardiovascular events in asymptomatic individuals. Sci Rep. 2021;11(1):4605.","journal-title":"Sci Rep"},{"issue":"3","key":"4751_CR34","doi-asserted-by":"publisher","first-page":"e89029","DOI":"10.1371\/journal.pone.0089029","volume":"9","author":"BR Palmer","year":"2014","unstructured":"Palmer BR, et al. Genetic polymorphism rs6922269 in the MTHFD1L gene is associated with survival and baseline active vitamin B12 levels in post-acute coronary syndromes patients. PLoS ONE. 2014;9(3):e89029.","journal-title":"PLoS ONE"},{"issue":"1","key":"4751_CR35","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1373\/clinchem.2016.257816","volume":"63","author":"TC Prickett","year":"2017","unstructured":"Prickett TC, et al. C-Type natriuretic peptides in coronary disease. Clin Chem. 2017;63(1):316\u201324.","journal-title":"Clin Chem"},{"issue":"3","key":"4751_CR36","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/S0735-1097(00)00889-5","volume":"36","author":"E Braunwald","year":"2000","unstructured":"Braunwald E, et al. ACC\/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American college of cardiology\/american heart association task force on practice guidelines (Committee on the management of patients with unstable Angina). J Am Coll Cardiol. 2000;36(3):970\u20131062.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"4751_CR37","first-page":"144","volume":"47","author":"BK Yadav","year":"2017","unstructured":"Yadav BK, et al. Genetic polymorphisms rs699947, rs1570360, and rs3025039 on the VEGF gene are correlated with extracranial internal carotid artery stenosis and ischemic stroke. Ann Clin Lab Sci. 2017;47(2):144\u201355.","journal-title":"Ann Clin Lab Sci"},{"issue":"2","key":"4751_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm9020469","volume":"9","author":"D Skrypnik","year":"2020","unstructured":"Skrypnik D, et al. Association of rs699947 (-2578\u00a0C\/A) and rs2010963 (-634 G\/C) single nucleotide polymorphisms of the VEGF gene, VEGF-A and leptin serum level, and cardiovascular risk in patients with excess body mass: A Case-Control study. J Clin Med. 2020;9(2):1\u201316.","journal-title":"J Clin Med"},{"issue":"6","key":"4751_CR39","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.5114\/aoms.2018.74757","volume":"14","author":"A Totomoch-Serra","year":"2018","unstructured":"Totomoch-Serra A, et al. Association of common polymorphisms in the and genes with type 2 diabetes-related traits in Mexicans. Archives Med Sci. 2018;14(6):1361\u201373.","journal-title":"Archives Med Sci"},{"issue":"2","key":"4751_CR40","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1194\/jlr.P030551","volume":"54","author":"MG Stathopoulou","year":"2013","unstructured":"Stathopoulou MG, et al. A common variant highly associated with plasma VEGFA levels also contributes to the variation of both LDL-C and HDL-C. J Lipid Res. 2013;54(2):535\u201341.","journal-title":"J Lipid Res"},{"key":"4751_CR41","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cyto.2018.03.003","volume":"106","author":"N Sellami","year":"2018","unstructured":"Sellami N, et al. Association of VEGFA variants with altered VEGF secretion and type 2 diabetes: A case-control study. Cytokine. 2018;106:29\u201334.","journal-title":"Cytokine"},{"key":"4751_CR42","doi-asserted-by":"crossref","unstructured":"Nia SK et al. The impact of vascular endothelial growth factor\u2009+\u2009405\u00a0C\/G polymorphism on long-term outcome and severity of coronary artery disease. J Clin Lab Anal, 2017. 31(4).","DOI":"10.1002\/jcla.22066"},{"key":"4751_CR43","doi-asserted-by":"publisher","first-page":"31","DOI":"10.12659\/MSM.895163","volume":"22","author":"L Li","year":"2016","unstructured":"Li L, et al. Association of genetic polymorphisms on vascular endothelial growth factor and its receptor genes with susceptibility to coronary heart disease. Med Sci Monit. 2016;22:31\u201340.","journal-title":"Med Sci Monit"},{"issue":"1","key":"4751_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12881-018-0628-3","volume":"19","author":"W-Q Ma","year":"2018","unstructured":"Ma W-Q, et al. Association of genetic polymorphisms in vascular endothelial growth factor with susceptibility to coronary artery disease: a meta\u2013analysis. BMC Med Genet. 2018;19(1):1\u201312.","journal-title":"BMC Med Genet"},{"issue":"5\u20136","key":"4751_CR45","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1080\/08977194.2018.1513505","volume":"36","author":"W Wang","year":"2018","unstructured":"Wang W, Xu A, Xu H. The roles of vascular endothelial growth factor gene polymorphisms in congenital heart diseases: a meta-analysis. Growth Factors. 2018;36(5\u20136):232\u20138.","journal-title":"Growth Factors"},{"key":"4751_CR46","doi-asserted-by":"crossref","unstructured":"Meza-Alvarado JC et al. VEGF-A related SNPs: a cardiovascular context. Front Cardiovasc Med, 2023. 10.","DOI":"10.3389\/fcvm.2023.1190513"},{"issue":"6","key":"4751_CR47","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1101\/gr.229102","volume":"12","author":"WJ Kent","year":"2002","unstructured":"Kent WJ, et al. The human genome browser at UCSC. Genome Res. 2002;12(6):996\u20131006.","journal-title":"Genome Res"},{"issue":"D1","key":"4751_CR48","doi-asserted-by":"publisher","first-page":"D933","DOI":"10.1093\/nar\/gkac958","volume":"51","author":"FJ Martin","year":"2022","unstructured":"Martin FJ, et al. Ensembl 2023. Nucleic Acids Res. 2022;51(D1):D933\u201341.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"4751_CR49","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/ng.3656","volume":"48","author":"S Das","year":"2016","unstructured":"Das S, et al. Next-generation genotype imputation service and methods. Nat Genet. 2016;48(10):1284\u20137.","journal-title":"Nat Genet"},{"issue":"D1","key":"4751_CR50","doi-asserted-by":"publisher","first-page":"D877","DOI":"10.1093\/nar\/gkv1340","volume":"44","author":"LD Ward","year":"2016","unstructured":"Ward LD, Kellis M. HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease. Nucleic Acids Res. 2016;44(D1):D877\u201381.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"4751_CR51","doi-asserted-by":"publisher","first-page":"D174","DOI":"10.1093\/nar\/gkad1059","volume":"52","author":"I Rauluseviciute","year":"2023","unstructured":"Rauluseviciute I, et al. JASPAR 2024: 20th anniversary of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 2023;52(D1):D174\u201382.","journal-title":"Nucleic Acids Res"},{"key":"4751_CR52","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.gene.2018.05.017","volume":"667","author":"H Ghazizadeh","year":"2018","unstructured":"Ghazizadeh H, et al. Association of rs6921438 A\u2009<\u2009G with serum vascular endothelial growth factor concentrations in patients with metabolic syndrome. Gene. 2018;667:70\u20135.","journal-title":"Gene"},{"key":"4751_CR53","doi-asserted-by":"publisher","first-page":"100813","DOI":"10.1016\/j.genrep.2020.100813","volume":"21","author":"H Ghazizadeh","year":"2020","unstructured":"Ghazizadeh H, et al. Interaction between a genetic variant in vascular endothelial growth factor with dietary intakes in association with the main factors of metabolic syndrome. Gene Rep. 2020;21:100813.","journal-title":"Gene Rep"},{"issue":"9","key":"4751_CR54","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1136\/jmedgenet-2018-105965","volume":"56","author":"E Sliz","year":"2019","unstructured":"Sliz E, et al. Genome-wide association study identifies seven novel loci associating with Circulating cytokines and cell adhesion molecules in Finns. J Med Genet. 2019;56(9):607\u201316.","journal-title":"J Med Genet"},{"issue":"11","key":"4751_CR55","doi-asserted-by":"publisher","first-page":"e1009163","DOI":"10.1371\/journal.pgen.1009163","volume":"16","author":"Y Wang","year":"2020","unstructured":"Wang Y, et al. Genome-wide association study identifies 16 genomic regions associated with Circulating cytokines at birth. PLoS Genet. 2020;16(11):e1009163.","journal-title":"PLoS Genet"},{"issue":"35","key":"4751_CR56","doi-asserted-by":"publisher","first-page":"e2121333119","DOI":"10.1073\/pnas.2121333119","volume":"119","author":"JR Ryu","year":"2022","unstructured":"Ryu JR, et al. Stroke-associated intergenic variants modulate a human FOXF2 transcriptional enhancer. Proc Natl Acad Sci United States Am (USA). 2022;119(35):e2121333119.","journal-title":"Proc Natl Acad Sci United States Am (USA)"},{"key":"4751_CR57","doi-asserted-by":"publisher","first-page":"e10845","DOI":"10.7717\/peerj.10845","volume":"9","author":"Q Wu","year":"2021","unstructured":"Wu Q, Li W, You C. The regulatory roles and mechanisms of the transcription factor FOXF2 in human diseases. PeerJ. 2021;9:e10845.","journal-title":"PeerJ"},{"key":"4751_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.01426","volume":"10","author":"E Fahey","year":"2019","unstructured":"Fahey E, Doyle SL. IL-1 family cytokine regulation of vascular permeability and angiogenesis. Front Immunol. 2019;10:1\u201315.","journal-title":"Front Immunol"},{"issue":"6","key":"4751_CR59","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.cytogfr.2015.04.003","volume":"26","author":"DP Ramji","year":"2015","unstructured":"Ramji DP, Davies TS. Cytokines in atherosclerosis: key players in all stages of disease and promising therapeutic targets. Cytokine Growth Factor Rev. 2015;26(6):673\u201385.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"4751_CR60","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.cyto.2012.10.024","volume":"61","author":"M Azimi-Nezhad","year":"2013","unstructured":"Azimi-Nezhad M, et al. Associations of vascular endothelial growth factor (VEGF) with adhesion and inflammation molecules in a healthy population. Cytokine. 2013;61(2):602\u20137.","journal-title":"Cytokine"},{"key":"4751_CR61","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3389\/fcvm.2019.00150","volume":"6","author":"Z Harhous","year":"2019","unstructured":"Harhous Z, et al. An update on the multifaceted roles of STAT3 in the heart. Front Cardiovasc Med. 2019;6:150.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"4751_CR62","doi-asserted-by":"publisher","first-page":"16332","DOI":"10.1038\/s41598-018-34506-4","volume":"8","author":"F Innocenti","year":"2018","unstructured":"Innocenti F, et al. Genetic variation determines VEGF-A plasma levels in cancer patients. Sci Rep. 2018;8(1):16332.","journal-title":"Sci Rep"},{"issue":"1","key":"4751_CR63","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jjcc.2023.04.017","volume":"83","author":"P Zhang","year":"2024","unstructured":"Zhang P, et al. The mechanism of the NFAT transcription factor family involved in oxidative stress response. J Cardiol. 2024;83(1):30\u20136.","journal-title":"J Cardiol"},{"key":"4751_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/1482194","volume":"2016","author":"S Merlo","year":"2016","unstructured":"Merlo S, et al. Vascular endothelial growth factor gene polymorphism (rs2010963) and its receptor, kinase insert Domain-Containing receptor gene polymorphism (rs2071559), and markers of carotid atherosclerosis in patients with type 2 diabetes mellitus. J Diabetes Res. 2016;2016:1\u20136.","journal-title":"J Diabetes Res"},{"issue":"19","key":"4751_CR65","doi-asserted-by":"publisher","first-page":"e3413","DOI":"10.1097\/MD.0000000000003413","volume":"95","author":"D Liu","year":"2016","unstructured":"Liu D, et al. Association of genetic polymorphisms on VEGFA and VEGFR2 with risk of coronary heart disease. Medicine. 2016;95(19):e3413.","journal-title":"Medicine"},{"issue":"24","key":"4751_CR66","doi-asserted-by":"publisher","first-page":"e022913","DOI":"10.1161\/JAHA.121.022913","volume":"10","author":"C O\u2019Donnell","year":"2021","unstructured":"O\u2019Donnell C, et al. N-Terminal Pro\u2010B\u2010Type natriuretic peptide as a biomarker for the severity and outcomes with COVID\u201019 in a nationwide hospitalized cohort. J Am Heart Association. 2021;10(24):e022913.","journal-title":"J Am Heart Association"},{"issue":"4","key":"4751_CR67","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.bcp.2012.11.021","volume":"85","author":"HE Tzeng","year":"2013","unstructured":"Tzeng HE, et al. Interleukin-6 induces vascular endothelial growth factor expression and promotes angiogenesis through apoptosis signal-regulating kinase 1 in human osteosarcoma. Biochem Pharmacol. 2013;85(4):531\u201340.","journal-title":"Biochem Pharmacol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04751-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-04751-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-04751-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T11:03:21Z","timestamp":1744887801000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-04751-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4751"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-04751-3","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"assertion":[{"value":"2 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The CDCS study was approved by the New Zealand (NZ) Multi-Region Ethics Committee, retrospectively registered at the Australian New Zealand Clinical Trials Registry (ACTRN12605000431628 on 16 September 2005), and all participating patients provided written, informed consent. The HVOL study was approved by the New Zealand Health and Disability Ethics Committee (Reference CTY\/01\/05\/062) and registered with the Australian New Zealand Clinical Trials Registry (ACTRN1260500448640). All participating patients provided written, informed consent. Both studies conform to the principles outlined in the Declaration of Helsinki and Title 45, U.S. Code of Federal Regulations, Part 46.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"Not applicable \u2013 this article does not report an individual participant\u2019s data in any form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication."}},{"value":"B.R.P. is a Senior Editorial Board Member of BMC Cardiovascular Disorders.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"290"}}